1 SiO2 Medical Products, Inc., Auburn, AL, USA.
2 Departments of Chemistry and Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
SLAS Technol. 2017 Feb;22(1):98-105. doi: 10.1177/2211068216666258. Epub 2016 Sep 26.
SiO Medical Products, Inc. (SiO) has developed a proprietary technology that greatly enhances protein recoveries and reduces extractables from commercial microplates used for bioanalytical assays and storage of biologics. SiO technology is based on plasma treatment that chemically modifies the surface of polypropylene with predominantly hydrogen-bond-acceptor uncharged polar groups. The resultant surface resists nonspecific protein adsorption over a wide range of protein concentrations, thereby eliminating the need to passivate (and hence potentially contaminate) the microplates with blocking proteins. High shelf-life stability and cleanliness of the plasma-treated microplates have been demonstrated using five different proteins for two common microplate formats. The protein recovery performance of plasma-treated microplates is found to be higher compared with commercial low-protein-binding microplates.
硅医疗产品公司(SiO)开发了一种专有技术,可极大提高商业微板在生物分析测定和生物制剂储存方面的蛋白质回收率,并降低提取物含量。SiO 技术基于等离子体处理,该处理通过化学方式用主要氢键受体非带电极性基团修饰聚丙烯表面。由此产生的表面在广泛的蛋白质浓度范围内抵抗非特异性蛋白质吸附,从而无需用封闭蛋白使微板钝化(并因此潜在地污染)。使用两种常见微板形式的五种不同蛋白质,已经证明等离子体处理微板具有较高的货架期稳定性和清洁度。与商业低蛋白结合微板相比,等离子体处理微板的蛋白质回收率性能更高。